Global Antipsychotic Drugs Market is expected to grow at a CAGR of 2.1% from 2017 to 2025. The report highlights the key trends, market outlook and the global scenario of the Global Antipsychotic Drugs Market. The market sizing is provided from 2016 to 2025, wherein the forecast is provided from 2017 to 2025. In addition, market dynamics (i.e. market drivers, market restraints and market opportunities) which covers factors supporting the market growth, factors restraining the market growth and factors behind the opportunities across this industry in the coming years has been included extensively under the scope of the study. The report also provides extensive detail of the market segments across type, application, and geography; market share of the key players globally and the competitive scenario throughout the forecast period, industry expert opinion, and profiles of the key players in the market. The major key players of the market are as follows:
KEY PLAYERS
ACADIA PHARMACEUTICALS, INC.
ALEMBIC PHARMACEUTICALS, LTD.
ALEXZA PHARMACEUTICALS
ALKERMES PLC
ALLERGAN PLC
APOTEX, INC.
ASTRAZENECA PLC
AUROBINDO PHARMA
DR. REDDY'S LABORATORIES LTD.
ELI LILLY AND CO.
GEDEON RICHTER PLC
JOHNSON & JOHNSON
LANNETT CO., INC.
H. LUNDBECK A/S
LUPIN, LTD.
MAYNE PHARMA, INC.
MYLAN NV
OTSUKA HOLDINGS CO., LTD.
SUMITOMO DAINIPPON PHARMA CO., LTD.
SUN PHARMACEUTICAL INDUSTRIES LIMITED (SUN PHARMA)
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
TORRENT PHARMACEUTICALS, LTD.
VANDA PHARMACEUTICALS, INC
WOCKHARDT
ZYDUS PHARMACEUTICALS (USA), INC.
Scope of the Market
Mechanism of Action Market
Global Antipsychotic Drug Market
D2 Antagonists
D2/5HT2A Antagonists
D2 Partial Agonists
Disease Indication Market
Schizophrenia
Bipolar Disorder
Major Depressive Disorder
Other Disease Indications
Geography Market
North America
Europe
Asia Pacific
Rest of the World (RoW)
Payment Options